Dynavax Technologies Corporation (Nasdaq: DVAX) announced an extension of the term of its research collaboration with its pharmaceutical partner AstraZeneca ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE